Novel Oncology Therapies in Combination With Adjuvant Chemo in High-risk MSS-CRC
Status:
Withdrawn
Trial end date:
2024-03-19
Target enrollment:
Participant gender:
Summary
Columbia 2 is a Phase 2 platform study to evaluate the safety and efficacy of standard of
care (FOLFOX) alone and in combination with novel oncology therapies in adjuvant high-risk
microsatellite-stable colorectal cancer